Navigation Links
Statement from Ralph G. Neas, President and CEO, Generic Pharmaceutical Association, on the Front Page New York Times Story Regarding the Pre-emptive Strikes of Amgen/Genentech to Restrict Access to Affordable and Safe Biosimilars
Date:1/29/2013

WASHINGTON, Jan. 29, 2013 /PRNewswire-USNewswire/ --Today's story shines a light on what essentially is a pre-emptive strike by Amgen and Genentech designed to choke the flow of safe and affordable life-saving biologic medicines to patients even before these products have been approved by the Food and Drug and Administration (FDA).  This is unfortunate because it puts profits ahead of the patients who need these treatments but many times cannot get them because of their prohibitively high cost.

The efforts highlighted in the Times story are doubly worrying for state legislators because not only will they slow availability of safe, effective and more affordable therapies to patients, but they also will dramatically decrease the much-needed cost savings that biosimilars will provide. At a time when legislators are desperately seeking ways to keep their state fiscally sound, these bills will encourage needless and wasteful spending on name brand therapies even after FDA-approved lower cost biosimilar products become available.

While in the guise of supporting biosimilar efforts, Amgen and Genentech are making every effort to limit consumer and patient access to safe and effective biosimilars in the future.

Biosimilar medicines, which are less costly versions of brand-name biologics, have been used safely in Europe for nearly seven years.  However, these affordable treatments are not yet available in the U.S.  But under new federal laws, the FDA now is developing regulations that will allow for the approval and use of biosimilars here at home.  Make no mistake: patient safety is paramount both for the FDA and for the companies that will make these medicines.  In fact, many of the companies who are working to develop biosimilars are the sam
'/>"/>

SOURCE Generic Pharmaceutical Association
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Icahn Issues Statement Regarding Amylin Pharmaceuticals
2. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
3. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
4. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
5. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
6. Lilly Statement on PDUFA Vote by Senate
7. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in the U.S. Senate
8. Lilly Statement on Affordable Care Act Ruling by Supreme Court
9. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
10. CRE Statement on "Inherent Reasonableness" for Retail Pharmacy Diabetic Supplies
11. Johnson Health Tech Statement on Lance Armstrong
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
(Date:7/23/2014)... , July 23, 2014 Creekridge ... have added 14 new vendors so far in ... Creekridge,s newest vendors are from both the ... domestic organizations to large, well-known multi-national companies. Each ... diversified suite of financing products including: standard leasing ...
(Date:7/23/2014)...  When it comes to welcoming our new robot overlords, ... out the red carpet. Healthcare is one of ... robots into our human sphere. With healthcare concerns top of ... to apply new technologies to help with old problems. That,s ... is expected to increase from $1.7 billion now to $3.7 ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Creekridge Capital Signs Several New Vendor Partners 2
... May 4 /PRNewswire-Asia-FirstCall/ -- Pharmaceutical,company Pharmaxis (ASX: PXS; Nasdaq: ... of its recently completed international Phase III trial of,Bronchitol(TM) ... one of,the largest clinical trials conducted in cystic fibrosis. ... the trial was to assess whether Bronchitol,improves lung function ...
... Calif., May 1 Isis Pharmaceuticals, Inc. (Nasdaq: ... presented data on numerous advanced programs from Isis, cardiovascular ... Thrombosis and Vascular Biology,s (ATVB) Annual Conference. The ... recently completed clinical study of mipomersen in which treatment ...
Cached Medicine Technology:Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 2Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 3Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 4Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial 5Isis and Collaborators Present New Research at the ATVB Annual Conference 2Isis and Collaborators Present New Research at the ATVB Annual Conference 3Isis and Collaborators Present New Research at the ATVB Annual Conference 4Isis and Collaborators Present New Research at the ATVB Annual Conference 5
(Date:7/24/2014)... Crawford Technologies today announced the ... with AIIM, focusing on global trends in high-volume ... the survey indicated that even though organizations stated ... customer service, legal and regulatory compliance and historical ... exact facsimiles of these documents. , The survey ...
(Date:7/24/2014)... Florida (PRWEB) July 24, 2014 After waiting ... and multiple injections later, Mrs. Ackerman decided it was time ... letter . She knew a surgical intervention was needed ... contacted the Orthopedic and Laser Spine Surgery Center for help. ... were sincere and professional. Even living in Montana, the connection ...
(Date:7/24/2014)... 24, 2014 Wisdom Natural Brands®, the ... SweetLeaf Stevia® Sweetener and Wisdom of the Ancients® herbal ... implementing innovative, high growth strategies. , Carol May, ... the executive leadership team today. “We are honored to ... brands into the future. The executives bring an impressive ...
(Date:7/24/2014)... 24, 2014 Professional Healthcare at Home, an ... Karen Schulkin, a nurse with the company’s Pleasant Hill, CA, ... Finalist for the 2014 Home Care & Hospice Nurse of ... Care & Hospice (NAHC). , Annually, NAHC promotes a ... public to help choose a top home care and hospice ...
(Date:7/24/2014)... July 24, 2014 According to ... 332,000 total hip replacements are performed in the ... Rosa Orthopedics (SRO) is a board certified orthopedic ... and pelvic & acetabular reconstruction. He specializes in ... minimally invasive technique that requires special training and ...
Breaking Medicine News(10 mins):Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 2Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 3Health News:AIIM Research Shows 56% of Organizations Not Utilizing Digital Archiving Technology 4Health News:Wisdom Natural Brands Announces Key Executive Management Team 2Health News:Wisdom Natural Brands Announces Key Executive Management Team 3Health News:Wisdom Natural Brands Announces Key Executive Management Team 4Health News:Wisdom Natural Brands Announces Key Executive Management Team 5Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 2Health News:Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year 3Health News:SRO Surgeon Nathan Ehmer Announces Less Invasive Anterior Approach to Hip Replacement Surgery to Help Speed Recovery Time 2Health News:SRO Surgeon Nathan Ehmer Announces Less Invasive Anterior Approach to Hip Replacement Surgery to Help Speed Recovery Time 3Health News:SRO Surgeon Nathan Ehmer Announces Less Invasive Anterior Approach to Hip Replacement Surgery to Help Speed Recovery Time 4
... different behavior to more time to cope, , MONDAY, ... how much time people have to react has a ... selflessly, if a new critique of the infamous Titanic ... The comparative look at who survived two of the ...
... ... Mattress Firm is pleased to announce they have joined forces with ... based in Houston, TX, is the nation,s leading specialty retailer of conventional ... full service, boutique franchise consulting firm with offices across the country. ...
... , ... ... ... ...
... ... ... ... ...
... ... ... ... ...
... team of researchers at UMass Lowell has found a new ... can spread within the human brain. The research, led ... hope that the disease may someday be cured. It provides ... human protein that becomes toxic in Alzheimer,s patients, can appear ...
Cached Medicine News:Health News:Titanic Passengers Less Selfish Than Some in Other Disasters 2Health News:Titanic Passengers Less Selfish Than Some in Other Disasters 3Health News:Titanic Passengers Less Selfish Than Some in Other Disasters 4Health News:Mattress Firm Partners with Upside Group Franchise Consulting 2Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 2Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 3Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 4Health News:GNC Says 'Thank You' to Customers and Employees for Their $1.4 Million in Donations to the Sixth Annual St. Jude Children's Research Hospital(R) Thanks and Giving(R) Campaign 5Health News:Chilean Quake Survivors Need Help: PADF 2Health News:Chilean Quake Survivors Need Help: PADF 3Health News:Chilean Quake Survivors Need Help: PADF 4Health News:Chilean Quake Survivors Need Help: PADF 5Health News:Chilean Quake Survivors Need Help: PADF 6Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 2Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 3Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 4Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 5Health News:Rhoads Named Director of Cancer Outreach Programs For Stanford Cancer Center, Cancer Prevention Institute of California 6
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: